YAKC Yak Communications

OTC Growth Stock Watch Upgrades YAK Communications Recommendation to 'Aggressive Buy' -- Target Price $16.00 Per Share in Twelve Months -- NEEDHAM, Mass., Sept. 29 /PRNewswire/ -- OTC Research Corporation, publisher of independent investment advisory newsletter, OTC Growth Stock Watch, announced today that it has upgraded its recommendation to an 'Aggressive Buy' on YAK Communications, Inc. (NASDAQ:YAKC). The 'Aggressive Buy' recommendation issued on YAK Communications is based on yesterday's news and includes a profile of the Company's comprehensive business strategies, unique concept, recent developments and impressive growth to-date. Visit http://www.otcgsw.com/ or call 781-444-6100 for detailed subscription information or for a copy of the updated report. Geoffrey Eiten, president of OTC Research Corp. and publisher of OTC Growth Stock Watch, said, "At under $8 per share, YAK Communications is extremely undervalued. Since our previous buy recommendation, we have seen a number of positive developments from the Company that support its long term growth prospects and an aggressive buy- with sales increasing as expected while development costs are absorbed. At current growth levels, our target price in the next twelve months is $16.00 per share, which could substantially increase if the Company's sales and earnings exceed our expectations." About OTC Growth Stock Watch OTC Growth Stock Watch (OTC-GSW) is a subscriber-based newsletter that accepts no outside advertising and is not compensated for its recommendations. Published since 1979, OTC-GSW is a registered investment advisor with the Securities and Exchange Commission and has earned its place as one of the most respected and referred-to guides to discovering high-performance NASDAQ(R) Stocks. OTC-GSW is regularly referenced by Barrons, Fortune, the Dick Davis Digest, and CNBC's Market Mavens and other leading financial news sources. Publisher Geoffrey Eiten's commentary on the latest developments in the various financial markets appears each month in the newsletter. Each issue of OTC Growth Stock Watch also features one in-depth company report printed in a straightforward, easy-to-read format. Each issues is also packed with the latest information on previously recommended stocks along with detailed, and specific advice to buy, sell or hold each given stock monthly. Geoffrey Eiten is a former stockbroker who holds a B.S. degree in Business Administration, with a major in Finance and Investments from Babson College and has been publishing OTC Growth Stock Watch, a subscriber-based investment advisory newsletter, for 25 years. Geared toward aggressive, growth-oriented investors, OTC Growth Stock Watch reports on companies with a market capitalization under $100 million dollars, which meet a set of Publisher and Registered Investment Advisor Geoffrey Eiten's rigid performance criteria: minimum 2-to-1 current ratio, minimal or no long-term debt, niche-oriented products and services, and an annual growth rate of over 20%. Since very few public corporations meet OTC Growth Stock Watch's rigid performance criteria, the GSW staff investigates hundreds of companies each month. After thorough research and analysis, OTC Growth Stock Watch is edited, printed, and mailed first-class, emailed or faxed to paid subscribers every month, guaranteeing current information for use right away. Visit http://www.otcgsw.com/ for further information and for detailed subscription information. Contact: Geoffrey Eiten, Publisher, 781-444-6100 x613 or . Disclaimer: OTC Growth Stock Watch, published by OTC Research Corp., endeavors to supply its subscribers with sound opinions and advice based on its analysis of publicly available information from sources believed to be reliable, but makes no representation as to its accuracy or completeness. Opinions and advice of OTC Growth Stock Watch are not based upon individual needs or investment objectives of subscribers nor are they an offer to buy or sell securities. Since many company issues featured may carry above average risk, OTC Growth Stock Watch recommendations should be bought only by investors financially able to purchase speculative stocks. OTC Growth Stock Watch, its affiliates and subsidiaries and/or their officers and employees may from time to time acquire, hold or sell a position in the securities mentioned in its newsletters. Upon request, the Company will be pleased to furnish specific information in this regard. Additional information on any securities discussed is available upon request. DATASOURCE: OTC Research Corporation CONTACT: Geoffrey Eiten, Publisher of OTC Research Corporation, +1-781-444-6100 ext. 613,

Copyright